NO

Nolato ABSTO Nolato Stock Report

Last reporting period 30 Jun, 2024

Updated 28 Oct, 2024

Last price

Market cap $B

1.053

Small

Exchange

XSTO - Nasdaq STOCKHOLM AB

NOLA B.ST Stock Analysis

NO

Avoid

Based on Eyestock quantitative analysis, NOLA B.ST`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

65/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-27.4 %

Greatly overvalued

Market cap $B

1.053

Dividend yield

2.58 %

Shares outstanding

241.78 B

Nolato AB engages in the development and manufacture of polymer product systems for customers in medical technology, telecommunications, hygiene, automotive products and other selected industrial sectors. The Company’s operations are divided into three operating segments. The Medical Solutions segment develops and manufactures complex product systems and components for medical devices, the pharmaceutical industry and diagnostics. The Integrated Solutions segments offers a wide range of technologies and expertise in a one-stop shop for areas including injection molding, casting, die-cutting, painting, decoration, assembly, testing and packaging of electronic products. The Industrial Solutionssegment develops and manufactures components and product systems for customers in the automotive industry, hygiene, packaging, gardening/ forestry, domestic appliances, furniture and other selected industrial segments. The firm operates worldwide.

View Section: Eyestock Rating